BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7579402)

  • 1. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex.
    Sugi T; McIntyre JA
    Blood; 1995 Oct; 86(8):3083-9. PubMed ID: 7579402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
    Sugi T; McIntyre JA
    J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity.
    Boffa MC; Berard M; Sugi T; McIntyre JA
    J Rheumatol; 1996 Aug; 23(8):1375-9. PubMed ID: 8856616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-phosphatidylethanolamine (aPE) antibodies: a survey.
    Mcintyre JA; Wagenknecht DR
    J Autoimmun; 2000 Sep; 15(2):185-93. PubMed ID: 10968907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies.
    Sugi T; Mclntyre JA
    Thromb Haemost; 1996 Sep; 76(3):354-60. PubMed ID: 8883270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to kininogen-phosphatidylethanolamine complexes augment thrombin-induced platelet aggregation.
    Sugi T; McIntyre JA
    Thromb Res; 1996 Oct; 84(2):97-109. PubMed ID: 8897699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outcome of ELISA for antiphosphatidylethanolamine antibodies is dependent on the composition of phosphatidylethanolamine.
    Hou S; Harper PE; Bardin N; Zhao M
    J Immunol Methods; 2017 Jan; 440():27-34. PubMed ID: 27784626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kininogen domain 3 contains regions recognized by antiphosphatidylethanolamine antibodies.
    Katsunuma J; Sugi T; Inomo A; Matsubayashi H; Izumi SI; Makino T
    J Thromb Haemost; 2003 Jan; 1(1):132-8. PubMed ID: 12871550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.
    Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM
    Autoimmunity; 1993; 16(4):245-9. PubMed ID: 8025204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains.
    Schmaier AH; Schutsky D; Farber A; Silver LD; Bradford HN; Colman RW
    J Biol Chem; 1987 Jan; 262(3):1405-11. PubMed ID: 2433279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELISA for antiphosphatidylethanolamine antibody detection: high impact of assay buffer on results.
    Sanmarco M
    J Immunol Methods; 2010 Jun; 358(1-2):9-16. PubMed ID: 20382150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular interaction of bovine kininogen and its derivatives with papain.
    Sueyoshi T; Hara A; Shimada T; Kimura M; Morita T; Kato H; Iwanaga S
    J Biochem; 1988 Aug; 104(2):200-6. PubMed ID: 3182763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [IGM hyperimmunoglobulinemia anti-phosphatidylethanolamine antibodies of the IgM isotype: clinical and biological study of 72 patients with immune disorders].
    Granel B; Serratrice J; Hubert AM; Volot F; Pache X; Swiader L; Rossi P; Disdier P; Weiller PJ
    Rev Med Interne; 2000 Jul; 21(7):595-8. PubMed ID: 10942975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
    Sanmarco M; Boffa MC
    Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kininogen-dependent antiphosphatidylethanolamine antibodies and autoantibodies to factor XII in patients with recurrent pregnancy losses.
    Sugi T
    J Obstet Gynaecol Res; 2013 Jul; 39(7):1223-9. PubMed ID: 23803004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies and kininogens in pathologic pregnancies: a review.
    Sugi T; Makino T
    Am J Reprod Immunol; 2002 May; 47(5):283-8. PubMed ID: 12148543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of Anti-Phosphatidylethanolamine Antibodies in the Pathogenesis of Recurrent Pregnancy Loss.
    Yonezawa M; Kuwabara Y; Ono S; Ouchi N; Ichikawa T; Takeshita T
    Reprod Sci; 2020 Oct; 27(10):1888-1893. PubMed ID: 32548803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome.
    Staub HL; Bertolaccini ML; Khamashta MA
    Autoimmun Rev; 2012 Dec; 12(2):230-4. PubMed ID: 22796282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic studies of human coagulation factor XI and its complex with high molecular weight kininogen.
    Bouma BN; Vlooswijk RA; Griffin JH
    Blood; 1983 Nov; 62(5):1123-31. PubMed ID: 6626744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of anti-phospholipid antibody specificities.
    Gilman-Sachs A; Lubinski J; Beer AE; Brend S; Beaman KD
    J Clin Lab Immunol; 1991 Jun; 35(2):83-8. PubMed ID: 1668762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.